Menopause hormone therapy (HRT) remains one of the most effective treatments for hot flashes, night sweats, vaginal dryness, and mood changes. But despite proven benefits, many women face uncertainty about insurance coverage. The good news: most major insurers now cover FDA-approved HRT formulations under the Affordable Care Act's Essential Health Benefits. The bad news: coverage varies significantly based on the type of HRT, your insurer, your state, and whether you are on Medicare.
HRT Formulation Coverage: What Insurers Typically Cover
Not all HRT is treated equally when it comes to insurance. FDA approval status, delivery method, and manufacturer all play a role.
| HRT Formulation | Typical Coverage | Typical Copay | Notes |
|---|---|---|---|
| Generic Estradiol Pills (Estrace generic) | Yes — widely covered | $10–$30/month | Tier 1 or 2 on most formularies. Most affordable option. |
| Estradiol Patches (Climara, Vivelle-Dot) | Usually covered — PA may be required | $40–$100/month | Commonly Tier 3. Some plans require trying pills first. |
| Estradiol Gel/Spray (Divigel, Evamist) | Sometimes covered | $50–$120/month | Brand-name products face higher denial rates. |
| Generic Progesterone (Prometrium generic) | Yes — widely covered | $10–$30/month | Required alongside estrogen for women with a uterus. |
| Compounded Bioidentical HRT | Usually NOT covered | N/A (cash pay $50–$250/month) | Not FDA-approved. Most insurers exclude compounded hormones. |
| Veozah (fezolinetant) | Often covered with PA | $0–$25/month with coupon | Non-hormonal option. $550/month list price; manufacturer coupon brings it to $0–$25. |
| Testosterone for Women (compounded) | Very rarely covered | N/A (cash pay $30–$80/month) | Not FDA-approved for women. Off-label use only. |
Insurer-by-Insurer HRT Coverage (2026)
| Insurer | Generic Estradiol Pills | Estradiol Patches | Compounded Bioidentical | Veozah | PA Required? |
|---|---|---|---|---|---|
| Aetna | Yes — Tier 1 | Yes — Tier 3, often PA | Not covered | Yes — PA + step therapy | Patches and Veozah |
| Cigna | Yes — Tier 1 | Yes — Tier 3, PA common | Not covered | Yes — PA required | Patches and Veozah |
| BCBS | Yes — Tier 1 or 2 | Varies by state, PA often required | Not covered | Yes — PA in most plans | Patches and Veozah |
| UHC | Yes — Tier 1 | Yes — Tier 3, PA common | Not covered | Yes — PA required | Patches and Veozah |
Medicare Part D and HRT Coverage
For women over 65 or with qualifying disabilities, Medicare Part D covers FDA-approved HRT:
- Generic estradiol pills: Almost always covered with low copays ($0–$10)
- Estradiol patches: Often covered but may be placed on Tier 3 or 4 with higher copays ($40–$80)
- Compounded HRT: Not covered under any Part D plan
- Veozah: Covered by most Part D plans with prior authorization and step therapy
- Progesterone (generic): Covered alongside estrogen for endometrial protection
Use the Medicare Plan Finder to compare formularies and costs for your specific Part D plan.
Ohio's 2026 Menopause Care Bill
In early 2026, Ohio became one of the first states to pass comprehensive legislation mandating insurance coverage for menopause care. The Ohio Menopause Care Access Act requires all private insurers and Medicaid plans in the state to:
- Cover FDA-approved HRT formulations (pills, patches, gels, vaginal preparations) without prior authorization for standard formulations
- Eliminate step therapy requirements for first-line HRT
- Reimburse telehealth visits with menopause specialists
- Provide clear, accessible formulary information for menopause treatments
- Limit cost-sharing for HRT prescriptions
This law is a landmark for women's health access. Other states — including California, New York, and Illinois — are considering similar legislation. If you live in Ohio, you should now be able to access standard HRT with significantly fewer barriers.
Note: Compounded bioidentical hormones remain excluded from the Ohio law, as they are not FDA-approved.
ACA Essential Health Benefits and HRT
Under the Affordable Care Act, all Marketplace plans and many employer-sponsored plans must cover Essential Health Benefits (EHBs). In 2026, FDA-approved HRT for menopause qualifies as part of EHBs, meaning:
- Insurers must cover FDA-approved HRT formulations
- No lifetime or annual limits on HRT coverage
- Coverage cannot be denied based on pre-existing conditions (including menopause)
- Women cannot be charged higher premiums due to menopause symptoms
However, the ACA does not mandate coverage for compounded or non-FDA-approved bioidentical hormones.
Getting Veozah Covered: Prior Authorization Tips
Veozah (fezolinetant) is a non-hormonal treatment for moderate-to-severe hot flashes approved in 2023. At $550/month list price, it is expensive, but the manufacturer coupon brings the cost to $0–$25/month for eligible patients.
To get Veozah approved through PA:
- Document failed prior treatments — show that you tried lifestyle modifications, low-dose HRT, or SSRIs without adequate relief
- Submit a treatment plan with a letter detailing symptom severity, vasomotor symptom frequency, and impact on quality of life
- Use the manufacturer coupon while PA is pending — the Veozah Patient Savings Program covers the cost during the approval process
- Appeal if denied — include clinical evidence from the SKYLIGHT trials showing Veozah's efficacy
Telehealth Providers for HRT Access
If insurance barriers are slowing your access to HRT, telehealth providers offer an alternative path:
- Winona: $89–$149/month all-inclusive for bioidentical HRT. Menopause-focused. FSA/HSA accepted.
- Kiaora (formerly Midi Health): Accepts select insurance plans. Specializes in midlife women's health.
- Hone Health: Lab-driven approach with comprehensive hormone panels. $249 initial + $89/month.
- Ivím Health: Both FDA-approved and compounded options with transparent pricing.
Do not let insurance delays keep you from relief. Whether you use insurance or telehealth, the right HRT can transform your experience of menopause. Compare providers at MedSwitcher to find your best option.